MEPPSTM performs advanced metabolomics analysis using chemoselective probes. Application of this method enhances the mass spectrometric sensitivity by a factor of up to six orders-of-magnitude (1 million) that will lead to the discovery of unidentified metabolites. This method advances the scope of metabolomics-driven biomarker discovery projects and can lead to the development of new therapeutics and…